Skip to main content

Table 4 Stepwise multiple linear regression analyses of glucolipid metabolism associated with pancreatic islet function

From: Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study

Variables

B

SE

Beta

P

95%CI

HOMA2-β

 FPG(mmol/L)

-2.665

0.307

-0.373

 < 0.001

-3.268 ~ -2.061

 2hCP(ng/ml)

2.503

0.337

0.238

 < 0.001

1.842 ~ 3.164

 FCP(ng/ml)

8.391

1.208

0.211

 < 0.001

6.018 ~ 10.765

 TyG

-7.794

1.904

-0.224

 < 0.001

-11.534 ~ -4.055

 FINS(mU/L)

0.383

0.108

0.095

 < 0.001

0.172 ~ 0.595

 HbA1C(%)

-1.195

0.410

-0.103

0.004

-2.001 ~ -0.390

 TG(mmol/L)

-1.261

0.480

-0.109

0.009

-2.205 ~ -0.318

HOMA2-IR

 FINS(mU/L)

0.096

0.006

0.553

 < 0.001

0.084 ~ 0.108

 FPG(mmol/L)

0.151

0.013

0.492

 < 0.001

0.125 ~ 0.177

 FCP(ng/ml)

0.197

0.061

0.116

0.001

0.078 ~ 0.316

 HbA1C(%)

0.057

0.022

0.113

0.011

0.013 ~ 0.100

 HDL(mmol/L)

-0.180

0.072

-0.074

0.012

-0.320 ~ -0.039

  1. Abbreviations: HOMA2-β homeostasis model assessment-2 beta-cell function, FPG fasting plasma glucose, 2hCP 2-h postprandial C-peptide, FCP fasting C-peptide, TyG triglyceride glucose index, FINS fasting insulin, HbA1C glycated hemoglobin, TG triglycerides, HOMA-2-IR homeostasis model assessment-2 insulin resistance, HDL high-density lipoprotein